Treatment with phytoestrogen alpha-zearalanol might protect neurons of hippocampus in ovariectomized rats.
Although neuroprotective effects of estrogen on postmenopausal women have been recognized, an associated increased incidence of uterine and breast tumors has jeopardized the clinical use of estrogen. This study was designed to evaluate the neuroprotective effects of a novel phytoestrogen alpha-zearalanol (alpha-ZAL), on ovariectomized (OVX) rats. Adult Wistar rats were ovariectomized or sham-operated and treatment with equivalent doses of 17beta-estradiol or alpha-ZAL for 5 wk. Uteruses have been weighted and stained by hematoxylin and eosin for morphology analysis. The expression of synaptophysin and parvalbumin in hippocampus were evaluated by immunohistochemistry assays. Our experiments indicated that the synaptophysin and parvalbumin-positive areas were significantly decreased in the OVX group compared to the sham group, alpha-ZAL or 17beta-estradiol administration can reverse the effects. Although alpha-ZAL and 17beta-estradiol treatments reconciled uterus weight loss which was induced by ovariectomy, the effect of alpha-ZAL was less than 17beta-estradiol. This result suggests that alpha-ZAL may effectively abate neurons loss in the hippocampus while slightly promoting weight gain of the uterus.
Dong
Yi-Long
YL
Institute of Basic Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China 100005.
Yue
Yun
Y
Liu
Feng-Hua
FH
Lang
Sen-Yang
SY
Zhang
Xiao-Chun
XC
Dai
Shun-Ling
SL
Ge
Qin-Sheng
QS
Zuo
Ping-Ping
PP
D000818:Animals; D004967:Estrogens / Q000097:blood; D005260:Female; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010052:Ovariectomy; D010320:Parvalbumins / Q000378:metabolism; D048789:Phytoestrogens / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D016708:Synaptophysin / Q000378:metabolism; D014599:Uterus / Q000187:drug effects / Q000473:pathology; D015029:Zeranol / Q000031:analogs & derivatives* / Q000494:pharmacology
D004967:Estrogens; D018696:Neuroprotective Agents; D010320:Parvalbumins; D048789:Phytoestrogens; D016708:Synaptophysin; C029659:zearalenol; D015029:Zeranol